Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2024-02-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于公司2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the year 2024. It includes information about the nature, amounts, pricing principles, and approval processes of these transactions. It also mentions the need for shareholder approval at an upcoming extraordinary general meeting. The document is not a financial report like an annual or interim report, nor is it a transcript, audit report, or earnings release. It is a regulatory announcement about related party transactions, which is a common type of regulatory filing in Chinese stock exchanges. The document is lengthy and detailed, but it primarily serves as a disclosure announcement rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS).
2024-02-05 Chinese
第六届董事会第六次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a company's board of directors meeting, specifically the sixth meeting of the sixth board. It includes information about the approval of a share repurchase plan, daily related party transactions forecast, and the scheduling of a shareholders meeting. The content focuses on board decisions and authorizations rather than financial results or reports. There is no indication of financial statements or earnings data, nor is it a simple announcement of a report publication. The document is not a regulatory certification or legal proceeding update. The primary focus is on board/management decisions and authorizations, which fits the category of Board/Management Information (MANG). The document length (4028 characters) and detailed meeting minutes support this classification.
2024-02-05 Chinese
关于召开2024年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2024 first extraordinary general meeting of shareholders for 盈康生命科技股份有限公司. It includes details about the meeting date, time, location, voting procedures, registration, and agenda items. It does not contain financial statements or results but is an announcement informing shareholders about the meeting and how to participate. The document length is 3675 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2024-02-05 Chinese
第六届监事会第五次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding the approval of a proposal on expected related party transactions for the year 2024. It includes details about the meeting date, attendance, voting results, and compliance with relevant laws and regulations. There is no financial data or comprehensive report content, but rather a formal announcement of a board meeting decision. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies. The document length is short and it is not an annual or interim report, nor an earnings release or regulatory filing. Therefore, the best classification is MANG with high confidence.
2024-02-05 Chinese
关于回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a company's plan to repurchase its own shares, including the purpose, funding, price range, quantity, implementation period, risks, and board authorization. It discusses the use of repurchased shares for employee stock ownership plans or equity incentives, the financial impact, and compliance with regulatory requirements. There is no financial statement or earnings data presented, nor is it a report or transcript. The content clearly fits the category of a share repurchase announcement, which corresponds to the 'Transaction in Own Shares' category (POS). The document length and detail confirm it is the announcement itself, not a brief notice or a report publication announcement.
2024-02-05 Chinese
2023年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2023 annual performance forecast (业绩预告) for the full fiscal year 2023 (January 1 to December 31, 2023). It provides estimated net profit figures and explanations for the expected performance change compared to the previous year. It explicitly states that the forecast has not been audited and that detailed audited data will be disclosed in the 2023 Annual Report. The document is short (869 characters) and serves as a preliminary earnings forecast rather than a full financial report. This type of document is best classified as an Earnings Release (ER), which is the initial announcement of periodic financial results with key highlights only. FY 2023
2024-01-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.